Position in SVRA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,753,157
-$4,344,352 QoQ
Shares Held
1,786,293
-23.6% QoQ
Ownership
0.872%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 184 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 97.81183713981973.ToString("F0")%
Shared 0.ToString("F0")%
None 2.188162860180273.ToString("F0")%
Common Shares in SVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,423,671,747 across 511 Biotechnology names. SVRA ranks #134 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in SVRA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,753,157 | 1,786,293 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $14,097,509 | 2,337,896 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $6,846,638 | 1,917,827 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $872,355 | 382,613 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $707,768 | 255,513 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,215,588 | 395,958 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,998,541 | 471,355 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $1,037,015 | 257,325 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $1,153,184 | 231,564 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,041,094 | 221,510 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $286,997 | 75,926 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $336,111 | 105,200 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $376,203 | 192,926 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $339,840 | 219,253 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $296,547 | 191,321 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $278,391 | 183,153 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $268,936 | 205,296 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $396,841 | 320,035 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $554,285 | 401,658 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $723,042 | 425,320 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $18,867 | 9,071 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $58,669 | 51,018 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $10,022 | 9,196 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $45,867 | 18,421 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $14,321 | 6,756 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||